89bio Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
89bio Inc ETNB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 24.33 20:00:00
Close Price Low Price High Price Open Price Previous Close
Bid Price Ask Price Spread News
23.47 24.49 1.02 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 24.33 USD

89bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 495.70M 20.37M 10.58M $ - $ - -27.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -165.91k -

more financials information »

89bio News

Date Time Source News Article
10/05/202009:02Edgar (US Regulatory)Current Report Filing (8-k)
9/28/202017:18GlobeNewswire Inc.89bio to Present at Upcoming Investor Conference
9/23/202017:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/23/202017:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/23/202007:00GlobeNewswire Inc.Longitude Capital Raises $585 Million Fund to Invest in..
9/21/202017:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
9/21/202016:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ETNB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week25.1725.352923.5124.09106,832-0.84-3.34%
1 Month24.6927.0022.2624.56156,682-0.36-1.46%
3 Months30.6542.3622.2627.31169,453-6.32-20.62%
6 Months27.3842.3618.013827.64126,422-3.05-11.14%
1 Year20.0047.253214.000127.4599,1654.3321.65%
3 Years20.0047.253214.000127.4599,1654.3321.65%
5 Years20.0047.253214.000127.4599,1654.3321.65%

89bio Description

89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, BIO89-100, is a long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201027 07:32:09